Catalyst Wire Dossier Catalyst Wire Dossier

GSK315234A

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSK315234A, covering 2016-12-01 to 2016-12-01. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study Evaluating the Safety and Efficacy of GSK315234A in Patients With Rheumatoid Arthritis [Phase 2]

See pricing